Brighton Jones LLC Athira Pharma, Inc. Transaction History
Brighton Jones LLC
- $2.96 Billion
- Q1 2025
A detailed history of Brighton Jones LLC transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Brighton Jones LLC holds 32,200 shares of ATHA stock, worth $8,694. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,200
Previous 32,200
-0.0%
Holding current value
$8,694
Previous $18,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ATHA
# of Institutions
61Shares Held
18.4MCall Options Held
14.3KPut Options Held
4.4K-
Perceptive Advisors LLC New York, NY5.4MShares$1.46 Million0.06% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.2MShares$864,1800.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.54MShares$415,2360.0% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.49MShares$403,0530.49% of portfolio
-
Simplify Asset Management Inc. New York, NY1.49MShares$403,0530.02% of portfolio
About Athira Pharma, Inc.
- Ticker ATHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,817,700
- Market Cap $10.2M
- Description
- Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...